Taiwan · Delayed Price · Currency is TWD Revivegen Statistics
Total Valuation
Revivegen has a market cap or net worth of TWD 768.08 million. The enterprise value is 813.51 million.
| Market Cap | 768.08M |
| Enterprise Value | 813.51M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Jul 23, 2026 |
Share Statistics
Revivegen has 32.00 million shares outstanding. The number of shares has decreased by -0.50% in one year.
| Current Share Class | 60.07M |
| Shares Outstanding | 32.00M |
| Shares Change (YoY) | -0.50% |
| Shares Change (QoQ) | -4.35% |
| Owned by Insiders (%) | 10.80% |
| Owned by Institutions (%) | n/a |
| Float | 31.54M |
Valuation Ratios
The trailing PE ratio is 80.03.
| PE Ratio | 80.03 |
| Forward PE | n/a |
| PS Ratio | 1.53 |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.54 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 44.50 |
| EV / Sales | 1.62 |
| EV / EBITDA | 5.16 |
| EV / EBIT | 37.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 2.04.
| Current Ratio | 0.56 |
| Quick Ratio | 0.50 |
| Debt / Equity | 2.04 |
| Debt / EBITDA | 31.48 |
| Debt / FCF | -5.54 |
| Interest Coverage | 2.29 |
Financial Efficiency
Return on equity (ROE) is -0.08% and return on invested capital (ROIC) is -0.07%.
| Return on Equity (ROE) | -0.08% |
| Return on Assets (ROA) | 0.18% |
| Return on Invested Capital (ROIC) | -0.07% |
| Return on Capital Employed (ROCE) | 0.32% |
| Weighted Average Cost of Capital (WACC) | 0.62% |
| Revenue Per Employee | 4.70M |
| Profits Per Employee | 170,860 |
| Employee Count | 107 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 152.52 |
Taxes
In the past 12 months, Revivegen has paid 9.95 million in taxes.
| Income Tax | 9.95M |
| Effective Tax Rate | 123.56% |
Stock Price Statistics
The stock price has decreased by -30.70% in the last 52 weeks. The beta is 0.13, so Revivegen's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -30.70% |
| 50-Day Moving Average | 26.34 |
| 200-Day Moving Average | 30.10 |
| Relative Strength Index (RSI) | 33.27 |
| Average Volume (20 Days) | 20,505 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Revivegen had revenue of TWD 502.49 million and earned 18.28 million in profits. Earnings per share was 0.30.
| Revenue | 502.49M |
| Gross Profit | 89.33M |
| Operating Income | 21.86M |
| Pretax Income | 8.05M |
| Net Income | 18.28M |
| EBITDA | 135.03M |
| EBIT | 21.86M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 328.18 million in cash and 4.96 billion in debt, with a net cash position of -4.64 billion or -144.84 per share.
| Cash & Cash Equivalents | 328.18M |
| Total Debt | 4.96B |
| Net Cash | -4.64B |
| Net Cash Per Share | -144.84 |
| Equity (Book Value) | 2.44B |
| Book Value Per Share | 24.74 |
| Working Capital | -374.36M |
Cash Flow
In the last 12 months, operating cash flow was 101.91 million and capital expenditures -997.74 million, giving a free cash flow of -895.83 million.
| Operating Cash Flow | 101.91M |
| Capital Expenditures | -997.74M |
| Depreciation & Amortization | 113.17M |
| Net Borrowing | 561.09M |
| Free Cash Flow | -895.83M |
| FCF Per Share | -27.99 |
Margins
Gross margin is 17.78%, with operating and profit margins of 4.35% and 3.64%.
| Gross Margin | 17.78% |
| Operating Margin | 4.35% |
| Pretax Margin | 1.60% |
| Profit Margin | 3.64% |
| EBITDA Margin | 26.87% |
| EBIT Margin | 4.35% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 1.37%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | -32.07% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 163.90% |
| Buyback Yield | 0.50% |
| Shareholder Yield | 1.87% |
| Earnings Yield | 2.38% |
| FCF Yield | -116.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.14.
| Last Split Date | Jul 26, 2024 |
| Split Type | Forward |
| Split Ratio | 1.14 |
Scores
Revivegen has an Altman Z-Score of 0.23 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.23 |
| Piotroski F-Score | 5 |